Skip to main content
. 2023;26(8):872–881. doi: 10.22038/IJBMS.2023.66364.14572

Table 3.

Clinical applications of mesenchymal stem cells in amyotrophic lateral sclerosis patients

graphic file with name IJBMS-26-872-g003.jpg